Tag: cse:lobe

Lobe Sciences (CSE:LOBE,OTCQB:LOBEF) has significantly expanded its portfolio following its acquisition of Altemia & Company. The purchase also sets Lobe Sciences up for revenue generation in the short term, helping…

Trip to Treatment: Lobe Sciences CEO Touts Targeted Low-dosing for Better Patient Outcomesyoutu.be Lobe Sciences (CSE:LOBE,OTCQB:LOBEF) is taking a different approach to psychedelic treatment by using low-dose, sub-psychedelic stimulation targeting…